Bailard’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,600
| Closed | -$38.4K | – | 793 |
|
|
2024
Q1 | $38.4K | Hold |
12,600
| – | – | ﹤0.01% | 729 |
|
|
2023
Q4 | $40.6K | Hold |
12,600
| – | – | ﹤0.01% | 702 |
|
|
2023
Q3 | $48.4K | Hold |
12,600
| – | – | ﹤0.01% | 689 |
|
|
2023
Q2 | $41.3K | Hold |
12,600
| – | – | ﹤0.01% | 682 |
|
|
2023
Q1 | $32.5K | Hold |
12,600
| – | – | ﹤0.01% | 708 |
|
|
2022
Q4 | $23.4K | Buy |
12,600
+800
| +7% | +$1.49K | ﹤0.01% | 700 |
|
|
2022
Q3 | $22K | Buy |
+11,800
| New | +$22K | ﹤0.01% | 658 |
|
|
2022
Q1 | – | Sell |
-47,948
| Closed | -$154K | – | 791 |
|
|
2021
Q4 | $154K | Buy |
+47,948
| New | +$154K | ﹤0.01% | 702 |
|